Welcome
RNA Australia will lead the development of a robust RNA research and development ecosystem in New South Wales. It was established in March 2023 as a joint venture between the NSW Government and five founding university member.
Key Objectives of RNA Australia:
- Support the sustainable operations of the RNA Research and Pilot Manufacturing Facility towards achieving the desired commercial RNA R&D, products and services.
- Develop and support R&D and commercialisation of world-leading relevant technologies and therapeutics.
- Accelerate RNA R&D into new commercial products, services and expertise including delivery of vaccine.
- Target RNA therapies in medical applications, agriculture, biosecurity and other relevant sectors.
- Improve accessibility of advanced RNA technology therapies for humans and animals.
- Boost a strong network between universities, research organisations, industries, entrepreneurs and investors.
- Foster essential skills and pathways for innovation, R&D, manufacturing and commercialisation.
Opportunity for:
- Access to Open-source GMP Facility (from 2025) aimed at scaling and producing RNA therapeutics for Phase 1-3 clinical trials alongside the NSW clinical trial system.
- Collaboration and partnership with industry and universities including the 14 NSW and ACT universities.
- Intellectual property development with support from the RNA ecosystem.
- Investment in RNA developments and other related RNA activities.